BOSTON (January 30, 2024) – Coin Metrics Inc., the leading provider of crypto financial intelligence, is pleased to announce the successful completion of a rigorous, independent audit of its index business’ adherence to the International Organization of Securities (“IOSCO”) Principles and the UK Benchmarks Regulation (“BMR”). The audit was conducted by PricewaterhouseCoopers LLP (“PwC”). Read full release here.
TraditionData – Try our Global FX & FX Options Data FREE for 90 days!
With ongoing global monetary policy revisions and capital markets uncertainty, the need for accurate, unbiased FX market data to keep pace with currency volatility is essential. TraditionData’s FX and FX Options market data packages are valuable resources to meet the growing demand for quality financial market data.
TraditionData would like to invite you to try our FX & FXO data free for 90 days. Simply click here and enter your details to register for this limited time offer.
Neudata Events for 2024
Learn from alternative data’s leading experts. Make life-long professional connections. Neudata presents a mix of virtual and in-person program of events suitable for public and private market investors, as well as corporations looking to explore alternative data sources, data providers and technology solutions providers. Learn more.
29th Feb – Boston Data Day for investors
26th March – London Data Summit
4th June – New York Summer Data Summit
26th Sept – San Francisco Data Summit
5th Dec – New York Winter Data Summit
dxFeed: 20% Revenue Growth and Getting Ahead of the Curve in Global Industry Trends
dxFeed is proud to announce a range of significant accomplishments and milestones achieved in 2023. The firm has demonstrated steady growth, innovation, and fintech industry recognition across AI, DeFi, IaaS, Index Management, and other segments. Read the full release here.
Introducing YipitData’s first ever Healthcare offering: The Medtech Granular Source Feed
In an industry reliant on lagged monthly data, our Medtech Granular Source Feed offering is poised to revolutionize the way investors look at Medtech data. Similar to the way credit card data reshaped the retail and restaurant industries, our offering will allow investors to have a daily, item level view of estimates of the U.S. revenue for 35+ medtech companies with MAPEs as low as of 1.2%. Read more here.
